Evidence map›Paper›PMID 11013220›Full record

ArticleThe EMBO journal2000

Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta.

X H Feng, X Lin, R Derynck

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 141 papers.

0numbers the graph read from it
0cells of the map it votes in
141citing papers in PubMed
11.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

141 citing papers in PubMed, 394 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Kinome-wide CRISPR-Cas9 screens revealedBiochemistry and biophysics reports · 2024
    Article
  5. Anticancer drugs: How to select small molecule combinations?Trends in pharmacological sciences · 2024
    Review
  6. TGF-β signaling in health, disease, and therapeutics.Signal transduction and targeted therapy · 2024
    Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. TGF-β Signaling in Progression of Oral Cancer.International journal of molecular sciences · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Smad3 Phospho-Isoform Signaling in Nonalcoholic Steatohepatitis.International journal of molecular sciences · 2022
    Review
  20. Article

81 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

X H FengDepartments of Growth and Development and Anatomy, and Programs in Cell Biology and Developmental Biology, University of California, San Francisco, CA 94143-0640, USA. xfeng@bcm.tmc.edu
X Lin
R Derynck
University of California, San Francisco · USBaylor College of Medicine · US

Funding

TGF BETA SIGNALING IN LUNG MORPHOGENESIS, INJURY AND REPAIRP01HL060231 · NHLBI · CHILDREN'S HOSPITAL OF LOS ANGELES · PI HEISTERKAMP, NORA C · 1998 to 2009
$14.5M
TGF-Beta and Smad-mediated regulation of gene expressionR01CA063101 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DERYNCK, RIK M · 1995 to 2014
$6.4M
NCI NIH HHS R01 CA063101NCI NIH HHS R01-CA63101NHLBI NIH HHS P01 HL060231NHLBI NIH HHS P01-HL60231
6 · The paper itself

Abstract

Transforming growth factor-beta (TGF-beta) arrests growth of epithelial cells by inducing the transcription of p15(Ink4B), a cyclin-dependent kinase inhibitor. In this study, we demonstrate that p15(Ink4B) induction was mediated by a TGF-beta-induced complex of Smad2, Smad3, Smad4 and Sp1. Mutations in the Sp1- or Smad-binding sequences decreased or abolished the TGF-beta responsiveness of the p15(Ink4B) promoter. Interference with, or deficiency in, Smad2, Smad3 or Smad4 functions also reduced or abolished the TGF-beta-dependent p15(Ink4B) induction, whereas the absence of Sp1 reduced the basal and TGF-beta-induced p15(Ink4B) transcription. In the nucleoprotein complex, Smad2 interacted through its C-domain with Sp1 and enhanced the DNA binding and transcriptional activity of Sp1. Smad3 interacted indirectly with Sp1 through its association with Smad2 and/or Smad4, and bound directly to the p15(Ink4B) promoter. Finally, Smad4 interacted through its N-domain with Sp1. Our data demonstrate the physical interactions and functional cooperativity of Sp1 with a complex of Smad2, Smad3 and Smad4 in the induction of the p15(Ink4B) gene. These findings explain the tumor suppressor roles of Smad2 and Smad4 in growth arrest signaling by TGF-beta.

Indexed as

Activin Receptors, Type ICell Cycle ProteinsCyclin-Dependent Kinase Inhibitor p16Tumor Suppressor ProteinsBlotting, NorthernCarrier ProteinsCell CycleCell LineCyclin-Dependent Kinase Inhibitor p15DNA-Binding ProteinsGenes, Tumor SuppressorGlutaminePromoter Regions, GeneticProtein BindingProtein Serine-Threonine KinasesReceptors, Transforming Growth Factor betaActivin Receptors, Type ICarrier ProteinsCell Cycle ProteinsCyclin-Dependent Kinase Inhibitor p15Cyclin-Dependent Kinase Inhibitor p16DNA-Binding ProteinsGlutamineProtein Serine-Threonine KinasesReceptors, Transforming Growth Factor betaReceptor, Transforming Growth Factor-beta Type IReceptor, Transforming Growth Factor-beta Type IISmad2 ProteinSmad3 ProteinSp1 Transcription FactorTrans-ActivatorsTransforming Growth Factor betaTumor Suppressor Proteins

Identifiers

PMID11013220
PMCPMC302105
OpenAlexW1966615054

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.